For a 2.5 mg target dose: Volume to Draw = Desired DoseConcentration = 2.5 mg10 mg/mL = 0.25 mL Convert to syringe units
A randomized, controlled, blinded human trial of GHK-Cu monotherapy, with a vehicle-only control (and a needling-plus-vehicle arm if a procedure is used), objective endpoints such as blinded global photography and target-area hair counts over at least several months, adequate statistical power, pre-registration, and independent replication
But it only works if the reconstituted solution remains stable for the full 12 weeks
Mechanisms of enterohepatic fibroblast growth factor 15/19 signaling in health and disease
Additionally, intracranial (superior sagittal sinus), portal, and caval hypertension and aortal hypotension were reduced, as were the grossly congested stomach and major hemorrhagic lesions, brain swelling, venous and arterial thrombosis, congested inferior caval and superior mesenteric veins, and collapsed azygos vein